The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
Supporting the era of green pharmaceuticals in the UK
To overcome the challenges and accelerate progress on carbon reduction and other sustainability goals, the pharmaceutical industry needs to engage in partnerships with the NHS and UK government, in addition to the need for more cross-industry collaboration. There are a number of high-priority activities that the NHS, UK government and industry should undertake to tackle these challenges.Read this OHE report
ABPI responds to Bioscience and health technology sector statistics 2021
The Office for Life Sciences today published economic data on Bioscience and health technology sector statistics 2021, which show stable levels of sector employment, and sharp growth in sector turnover.
ABPI response to Board of Trade report on Life Sciences
ABPI response to the UK Board of Trade’s latest report on the UK life sciences
Developing new antibiotics key for the race against resistant infections, says ABPI
World Antimicrobial Awareness Week aims to improve the awareness and understanding of antimicrobial resistance (AMR).
ABPI response to the Autumn Statement
The Association of the British Pharmaceutical Industry (ABPI) has welcomed Chancellor Jeremy Hunt’s Autumn Statement for recognising the vital role UK life sciences will play in delivering innovation-led growth.
Latest blogs and events
By coming together, we can overcome antimicrobial resistance
Reflections on World Antimicrobial Awareness Week 2022 from Dr Amit Aggarwal, ABPI Executive Director, Medical Affairs.
Reflections from NICON22
Commentary on this year's Northern Ireland Annual Conference and Exhibition 2022.
Could more medicines be recommended for routine commissioning rather than spending time in the Cancer Drugs Fund?
A new analysis commissioned by the ABPI suggests they could.
The Innovative Medicines Fund - Good news for patients but has an opportunity been missed to be more ambitious?
NHS England and Improvement (NHSE/I) has announced the launch of the Innovative Medicines Fund. The ABPI’s Director of Value and Access Policy, Paul Catchpole, provides further commentary on the announcement.
Key content hubs
This covers the latest research from the ABPI-Ipsos attitudes towards pharmaceutical companies in the UK study.
We stand in solidarity with the people of Ukraine and condemn the invasion of their country. As an industry dedicated to saving lives, we stand for peace.
As a critical part of the health care community in the UK, the pharmaceutical industry wants to play the biggest possible role in the response to COVID-19.
The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.
The International Clinical Researcher of the Year Clinical Site Team Award is back for 2023 sponsored by the NIHR and @ABPI_UK 🏆— NIHR for Industry (@NIHR_Industry) December 1, 2022
Entries are invited from highly motivated teams, committed to excellence.
Do you know a team like that?
Share the link: https://t.co/6BjloZzV2z pic.twitter.com/LFxCEJCf0D
UKG minister for Scotland @john2win attended the launch of the Medicines Manufacturing Innovation Centre, a state-of-the-art facility led by @ukCPI to develop & commercialise technologies that improve medicines manufacturing. #ConnectingPharma #LetsInnovateTogether #CPIPharma pic.twitter.com/qryxfNNdsW— Office of the Secretary of State for Scotland (@ScotSecofState) November 30, 2022
Great to see the MMIC launched and look forward to it boosting UK innovation 🔽 https://t.co/lodu3r5z7J— ABPI (@ABPI_UK) November 30, 2022